Skip to content

postoperative effect of optimal pain management supplemented with a single dose of adrenocortical hormon in the first week after insertion of a knee prosthesis

postoperative effect of optimal multimodal pain management supplemented with systemic single dose of Dexamethason in the first week after UKA. Low dose (8mg) or mean dose

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2017-003003-22-DK
Enrollment
70
Registered
2017-10-10
Start date
2017-11-27
Completion date
Unknown
Last updated
2020-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis MedDRA version: 20.0 Level: LLT Classification code 10031165 Term: Osteoarthritis knee System Organ Class: 100000004859

Interventions

Trade Name: Dexametasone Product Name: Dexamethasone "KRKA" injektionsvæske, opløsning 4mg/ml Product Code: 29721 Pharmaceutical Form: Infusion INN or Proposed INN: DEXAMETHASONE DIPROPIONATE CAS Numb

Sponsors

Aalborg University Hospital, Department of Orthopedics
Lead Sponsor
Mogens Brouw Jørgensen
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients =65 years) yes F.1.3.1 Number of subjects for this age range 35

Exclusion criteria

Exclusion criteria: Fertil women, daily use of opioids, NSAID or glucocorticoid, allergi to medicin used in the trial,alcohol abuse, cognictive dysfunction, severe kidney or hesrt disease, language barrier, operation in generel anaesthesia

Design outcomes

Primary

MeasureTime frame
Main Objective: Pain management i the first week after UKA;Secondary Objective: opiod use in the first week after UKA;Primary end point(s): knee pain, opioid use, knee swelling, PONV in the first week after UKA;Timepoint(s) of evaluation of this end point: one week after UKA

Secondary

MeasureTime frame
Secondary end point(s): wound complications in the first week after UKA;Timepoint(s) of evaluation of this end point: one week after UKA

Countries

Denmark

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026